Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Jarlais DD.

J Urban Health. 2009 Nov;86(6):918-28. doi: 10.1007/s11524-009-9400-5. Epub 2009 Nov 18.

2.

Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.

Lewis BA, Koester SK, Bush TW.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S46-51.

PMID:
12489615
3.
4.

Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.

Fedorova EV, Skochilov RV, Heimer R, Case P, Beletsky L, Grau LE, Kozlov AP, Shaboltas AV.

BMC Public Health. 2013 Mar 1;13:183. doi: 10.1186/1471-2458-13-183.

5.

Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

Wright-De Agüero L, Weinstein B, Jones TS, Miles J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S102-10.

PMID:
9663632
6.

Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.

Costenbader EC, Zule WA, Coomes CC.

Int J Drug Policy. 2010 Sep;21(5):425-8. doi: 10.1016/j.drugpo.2009.12.006. Epub 2010 Jan 22.

7.

Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.

Zaller ND, Yokell MA, Nayak SM, Fu JJ, Bazazi AR, Rich JD.

J Urban Health. 2012 Aug;89(4):659-70. doi: 10.1007/s11524-012-9669-7.

8.

Injection drug users report good access to pharmacy sale of syringes.

Reich W, Compton WM, Horton JC, Cottler LB, Cunningham-Williams RM, Booth R, Singer M, Leukefeld C, Fink J, Stopka TJ, Corsi KF, Tindall MS.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S68-72.

PMID:
12489619
9.

Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.

Case P, Beckett GA, Jones TS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S94-101.

PMID:
9663631
10.

Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC.

Harm Reduct J. 2009 Feb 20;6:3. doi: 10.1186/1477-7517-6-3.

12.

Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.

Lutnick A, Case P, Kral AH.

J Urban Health. 2012 Apr;89(2):354-64. doi: 10.1007/s11524-011-9651-9.

13.
14.

Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.

Taussig JA, Weinstein B, Burris S, Jones TS.

AIDS. 2000 Jun;14 Suppl 1:S47-51.

PMID:
10981474
15.

Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.

Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN.

J Urban Health. 2010 Jul;87(4):534-42. doi: 10.1007/s11524-010-9468-y.

16.

Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.

Ghaddar A, Nassar K, Elsoury G.

Subst Use Misuse. 2017 Sep 19;52(11):1420-1428. doi: 10.1080/10826084.2017.1284235. Epub 2017 Apr 21.

PMID:
28430013
17.

Pharmacist ambivalence about sale of syringes to injection drug users.

Reich W, Compton WM, Horton JC, Cottler LB, Cunningham-Williams RM, Booth R, Singer M, Leukefeld C, Fink J, Stopka T, Corsi KF, Tindall MS.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S52-7.

PMID:
12489616
18.

Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.

Rudolph AE, Crawford ND, Ompad DC, Benjamin EO, Stern RJ, Fuller CM.

J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):140-7. doi: 10.1331/JAPhA.2010.09193.

19.

Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention.

Zaller ND, Yokell MA, Apeakorang N, Gaggin J, Case P.

J Health Care Poor Underserved. 2012 Aug;23(3):1310-26. doi: 10.1353/hpu.2012.0094.

PMID:
24212176
20.

The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.

Myers T, Cockerill R, Millson M, Rankin J, Worthington C.

AIDS Public Policy J. 1996 Summer;11(2):78-88.

PMID:
10915241

Supplemental Content

Support Center